  We report the detection of Nipah virus in an infectious clone format, a
BSL4-level pathogen and CDC-designated Bioterrorism Agent, in raw RNA-Seq
sequencing reads deposited by the Wuhan Institute of Virology (WIV) produced
from five December 2019 patients infected with SARS-CoV-2. Research involving
Nipah infectious clones has never been reported to have occured at the WIV.
These patient samples have been previously reported to contain reads from
several other viruses: Influenza A, Spodoptera frugiperda rhabdovirus and
Nipah. Previous authors have interpreted the presence of these virus sequences
as indicative of co-infections of the patients in question by these pathogens
or laboratory contamination. However, our analysis shows that NiV genes are
encapsulated in synthetic vectors, which we infer was for assembly of a NiV
infectious clone. In particular, we document the finding of internal N, P-V-W-C
and L protein coding sequences as well as coverage of the G and F genes.
Furthermore, the format of Hepatitis D virus ribozyme and T7 terminator
downstream of the 5-prime end of the NiV sequence is consistent with truncation
required at the end of the genome for a full length infectious clone. This
indicates that research at WIV was being conducted on an assembled NiV
infectious clone. Contamination of patient sequencing reads by an infectious
NiV clone of the highly pathogenic Bangladesh strain could indicate a
significant breach of BSL-4 protocols. We call on WIV to explain the purpose of
this research on infectious clones of Nipah Virus, the full chronology of this
work, and to explain how and at what stage of sample preparation this
contamination occurred.
